Recent Articles from GlobeNewswire
Patent strengthens Turbo Energy’s competitive positioning in the rapidly expanding U.S. residential EV charging market and supports the nationwide rollout of its SUNBOX® intelligent energy platform
By Turbo Energy S.A. · Via GlobeNewswire · April 9, 2026
Company Publishes Investor Presentation Outlining the Combined Nuvini and Beyondsoft Platform
By Nvni Group Limited · Via GlobeNewswire · April 9, 2026
Fireside Chat to explore how communities can move from uncertainty to informed infrastructure planning through frameworks, engagement, and practical implementation
By iMiller Public Relations · Via GlobeNewswire · April 9, 2026
DENVER, April 09, 2026 (GLOBE NEWSWIRE) -- American Rare Earths (ASX: ARR | OTCQX: ARRNF | ADR: AMRRY) (“ARR” or the “Company”) is pleased to announce the next stage in its accelerated pilot plant program for the American Rare Earths Halleck Creek Project in Wyoming, with initial processing to be undertaken in Wyoming through DISA Technologies (“DISA”) and Western Research Institute followed by final stage hydrometallurgical processing and oxide separation at the Saskatchewan Research Council (“SRC”) in Saskatoon, Saskatchewan, Canada. The Company has executed agreements with Western Research Institute, DISA and SRC to provide mineral processing activities at their respective locations.
By American Rare Earths · Via GlobeNewswire · April 9, 2026
By AirJoule Technologies Corporation · Via GlobeNewswire · April 9, 2026
Continued Focus on People, Products, Planet and Governance
By nVent · Via GlobeNewswire · April 9, 2026
EMERYVILLE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Kyverna Therapeutics, Inc. (Kyverna, Nasdaq: KYTX), a late-stage clinical biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases, today announced it will host a conference call on Wednesday, April 22, 2026 at 7:00 a.m. ET to discuss the primary analysis from its KYSA-8 registrational trial of miv-cel (mivocabtagene autoleucel, KYV-101) in stiff person syndrome, along with longer-term follow-up data from the KYSA-6 Phase 2 trial in generalized myasthenia gravis (gMG). These data will be shared as oral presentations at the American Academy of Neurology (AAN) Annual Meeting, held April 18-22, 2026, in Chicago.
By Kyverna Therapeutics, Inc. · Via GlobeNewswire · April 9, 2026
A 977-kilowatt solar system in Palm Desert marks a new era: apartment buildings that don’t just consume power, they strengthen the grid
By PearlX Infrastructure · Via GlobeNewswire · April 9, 2026
Ingelheim, Germany – 9 April, 2026 – Boehringer Ingelheim today announced a clinical trial collaboration with BioNTech to evaluate a novel immuno‑oncology combination in extensive‑stage small cell lung cancer (ES-SCLC), one of the most aggressive and underserved forms of cancer. Under the agreement, BioNTech will supply pumitamig (BNT327/BMS‑986545), a PD‑L1/VEGF‑A bispecific antibody being jointly developed by BioNTech and Bristol Myers Squibb, and Boehringer Ingelheim will be the regulatory sponsor of the Phase Ib/II study. The aim is to assess safety, tolerability and early clinical activity of obrixtamig (BI 764532), Boehringer Ingelheim’s investigational DLL3/CD3 T‑cell engager, in combination with pumitamig.
By Boehringer Ingelheim Limited · Via GlobeNewswire · April 9, 2026
Important ophthalmic treatment expected to be an important growth driver for Amneal’s Affordable Medicines segment
By Amneal Pharmaceuticals LLC · Via GlobeNewswire · April 9, 2026
Live video webcast with Tom Equels, Chief Executive Officer of AIM ImmunoTech, on Thursday, April 16th at 4:00 PM ET
By AIM ImmunoTech Inc. · Via GlobeNewswire · April 9, 2026
By BitMEX · Via GlobeNewswire · April 9, 2026
Seer’s Proteograph will be used to generate enhanced proteomic insights in one of the world’s largest multi-omic health studies
By Seer, Inc. · Via GlobeNewswire · April 9, 2026
POMPANO BEACH, Fla., April 09, 2026 (GLOBE NEWSWIRE) -- Curonix LLC, a leading medical technology company dedicated to relieving chronic pain, today announced the appointment of Don Payerle, a seasoned healthcare executive, to its Board of Managers, effective immediately.
By Curonix LLC · Via GlobeNewswire · April 9, 2026
Veteran channel leader joins Freshworks to accelerate partner-led growth with a focus on Global System Integrators and upmarket expansion
By Freshworks Inc · Via GlobeNewswire · April 9, 2026
By NMI Holdings, Inc. · Via GlobeNewswire · April 9, 2026
Partnerships fuel awareness, research and support for people impacted by bladder cancer
By Bladder Cancer Advocacy Network · Via GlobeNewswire · April 9, 2026
– Additional Phase 1b data for ABI-5366, including results from monthly dosing cohort, selected for oral presentation –
By Assembly Biosciences, Inc. · Via GlobeNewswire · April 9, 2026
BriteCore to enhance operational efficiency, strengthen risk management, and support business expansion for regional nonstandard auto insurer
By BriteCore · Via GlobeNewswire · April 9, 2026
BOSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine diseases, today announced that it will host a live conference call and webcast at 8 a.m. ET on Tuesday, May 5, 2026 to report its first quarter 2026 financial results and provide a corporate update.
By Rhythm Pharmaceuticals, Inc. · Via GlobeNewswire · April 9, 2026
ORANGE, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC), will release its first quarter 2026 financial results on Thursday, April 30, 2026, after market close. Following the release, the company will host a conference call to review its financial results at 5 p.m. EDT.
By Alignment Healthcare USA, LLC · Via GlobeNewswire · April 9, 2026
Visa Direct integration supports a new on-ramp capability across OwlPay's product suite, enabling eligible U.S. debit cardholders to fund USDC transactions without a standalone exchange account
By OwlTing Group · Via GlobeNewswire · April 9, 2026
WUXI, China, April 09, 2026 (GLOBE NEWSWIRE) -- LOBO TECHNOLOGIES LTD. (NASDAQ: LOBO) (“LOBO” or the “Company”), an innovative electric mobility vehicles manufacturer and seller, today announced the official launch of its self-developed Claw AI Agent Platform (www.loboaiclaw.com), a solution tailored for the export-oriented manufacturing sector.
By LOBO EV TECHNOLOGIES LTD. · Via GlobeNewswire · April 9, 2026
Company executives will discuss their business strategies, provide updates on recent developments, and answer questions live from investors
By Virtual Investor Conferences · Via GlobeNewswire · April 9, 2026
SEATTLE, April 09, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the first quarter 2026 before market open on Tuesday, April 28, 2026.
By Nautilus Biotechnology Inc. · Via GlobeNewswire · April 9, 2026
Transaction provides liquidity and rollover options to investors while supporting continued growth of three high-quality companies
By ONEX Corporation · Via GlobeNewswire · April 9, 2026
LONDON, Ontario, April 09, 2026 (GLOBE NEWSWIRE) -- Aduro Clean Technologies Inc. (“Aduro” or the “Company”) (Nasdaq: ADUR) (CSE: ACT) (FSE: 9D5), a clean technology company using the power of chemistry to transform lower value feedstocks, like waste plastics, heavy bitumen, and renewable oils, into resources for the 21st century, today announced the award of a contract to Ebert HERA B.V. (“Ebert HERA”) to lead the permitting process for its First-of-a-Kind (“FOAK”) industrial facility at Chemelot Industrial Park in Sittard-Geleen, the Netherlands.
By Aduro Clean Technologies Inc. · Via GlobeNewswire · April 9, 2026
New integration delivers on Noom's pledge to the CMS Health Technology Ecosystem initiative to enable deeper personalization within Noom’s diabetes and obesity programs
By Noom Inc · Via GlobeNewswire · April 9, 2026
BOSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Cerevance, a clinical-stage biopharmaceutical company advancing targeted therapies for neurodegenerative diseases and obesity, today announced upcoming presentations at the American Academy of Neurology (AAN) 2026 Annual Meeting being held from April 18-22 in Chicago.
By Cerevance, Inc. · Via GlobeNewswire · April 9, 2026
KUALA LUMPUR, April 09, 2026 (GLOBE NEWSWIRE) -- WF Holding Limited (the “Company”) (NASDAQ: WFF), a Malaysia-based manufacturer of fiberglass reinforced plastic products, today announced that the shareholders and the board of directors of the Company approved a one-for-five reverse share split of the Company’s issued and unissued ordinary shares. Beginning April 13, 2026, the Company’s ordinary shares will be trading on a split-adjusted basis under the same symbol “WFF” but with a new CUSIP number, G9627R115, and a new par value of $0.00025 per share.
By WF HOLDING LIMITED · Via GlobeNewswire · April 9, 2026
BMC Psychiatry publication reports statistically significant reductions in self-injury behaviors and depressive symptoms, with brain-network findings further supporting Nexalin’s differentiated, non-invasive DIFS approach
By Nexalin Technology, Inc. · Via GlobeNewswire · April 9, 2026
Vancouver, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce further positive oxide antimony-gold drill results at its Limousine Butte Project (the “Project”, “Limo Butte”) in Nevada. All holes completed in the 2025 drill program are now released, with further assays pending on the 35 holes completed on the Crushed and Run of Mine (“ROM”) historical gold leach pads. The Company is focused on completing the maiden antimony-gold Mineral Resource Estimate (“MRE”) in Q2-2026. The maiden MRE is a key step in the development of Limo Butte with the objective of achieving near-term antimony production by 2027 from the historical gold leach pads, while also advancing the rest of the Project for future gold-antimony development.
By NevGold Corp. · Via GlobeNewswire · April 9, 2026
ENGLEWOOD, Colo., April 09, 2026 (GLOBE NEWSWIRE) -- Sling TV, the most flexible TV streaming platform, today announced the nationwide launch of Sling Essentials. Ideal for sports fans, families, and classic TV enthusiasts, Sling Essentials offers an unbeatable price for streaming ESPN and more at just $19.99 per month.
By Sling TV · Via GlobeNewswire · April 9, 2026
WASHINGTON, April 09, 2026 (GLOBE NEWSWIRE) -- FTI Consulting, Inc. (NYSE: FCN) today announced that it will release financial results for the first quarter ended March 31, 2026 before the New York market opens on Thursday, April 30, 2026.
By FTI Consulting, Inc. · Via GlobeNewswire · April 9, 2026
Signing of Second Long-Term Agreement with Major Aerospace and Defense Customer in 2026, Demonstrating Continued Customer Confidence and Contract Momentum
By PMGC Holdings Inc. · Via GlobeNewswire · April 9, 2026
Results from the first-ever randomized control trial for the REGENETEN Implant in partial-thickness rotator cuff repair
By Smith & Nephew UK Ltd · Via GlobeNewswire · April 9, 2026
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (Nasdaq: WW) (“Weight Watchers” or the “Company”), the global leader in science-backed weight management, today announced the following updates to the composition of its Board of Directors’ standing committees following the appointments of Lisa Gavales and Sue Gove as independent directors:
By WW International Inc. · Via GlobeNewswire · April 9, 2026
MONTREAL, April 09, 2026 (GLOBE NEWSWIRE) -- Bombardier (TSX: BBD.B) will publish its financial results for the first quarter of 2026 on April 30, 2026. That same day, Bombardier will hold its Annual General Meeting of Shareholders (“Meeting”) in a virtual format.
By Bombardier Inc. · Via GlobeNewswire · April 9, 2026
DALLAS, April 09, 2026 (GLOBE NEWSWIRE) -- AMN Healthcare Services, Inc. (NYSE: AMN), has scheduled a conference call to discuss its first quarter 2026 financial results and second quarter 2026 outlook on Thursday, May 7, 2026, at 5:00 p.m. Eastern Time. On the same day, the Company also expects to issue an earnings news release after market close at approximately 4:15 p.m. Eastern Time.
By AMN Healthcare Services Inc · Via GlobeNewswire · April 9, 2026
Agreement highlights growing demand for calibrated, consistent data powering AI-driven Earth intelligence
By EarthDaily Analytics · Via GlobeNewswire · April 9, 2026
Exodus Pay gives users a single app to spend with merchants, send money instantly, and earn rewards, all while keeping full custody
By Exodus · Via GlobeNewswire · April 9, 2026
Planning to travel alone? New iVisa data shows that solo applicants are at far greater risk of visa denial.
By iVisa · Via GlobeNewswire · April 9, 2026
NEW HAVEN, Conn., April 09, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced progress in its REVOLUTION clinical program for VYD2311, a novel monoclonal antibody investigational candidate for the prevention of symptomatic COVID-19. Invivyd also announced today the discovery and advancement of a novel, potentially first- and best-in-class measles monoclonal antibody candidate for treatment and prevention of measles discovered using Invivyd’s proprietary technology.
By Invivyd · Via GlobeNewswire · April 9, 2026
Industry veteran Ajit Kara joins GXO as Senior Vice President of Account Management
By GXO Logistics · Via GlobeNewswire · April 9, 2026
SINGAPORE, April 09, 2026 (GLOBE NEWSWIRE) -- Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services, today announced the official launch of Modellix.ai, a unified multimodal AI platform that provides a seamless, standardized bridge to global elite image and video models, transforming fragmented AI capabilities into scalable business innovation.
By Aurora Mobile Limited · Via GlobeNewswire · April 9, 2026
NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Cardiff Lexington Corporation (OTCQX: CDIX), a publicly traded healthcare services holding company focused on orthopedic, spine, and pain management platforms , has qualified to trade on the OTCQX® Best Market. Cardiff Lexington Corporation upgraded to OTCQX from the OTCQB® Venture Market.
By OTC Markets · Via GlobeNewswire · April 9, 2026
SAINT HELIER, Jersey — April 7, 2026 — CoinShares PLC ("CoinShares" or "the Group") (Nasdaq: CSHR), a leading global asset manager specializing in digital assets, today announced that Jean-Marie Mognetti, President, Chief Executive Officer and Co-Founder, will participate in the Centri Capital Conference 2026 on 14 April 2026 at 11:30 AM ET.
By CoinShares International Limited · Via GlobeNewswire · April 9, 2026
SOUTH SAN FRANCISCO, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a clinical-stage biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat autoimmune diseases, today announced its participation in the 25th Annual Needham Virtual Healthcare Conference.
By Nkarta, Inc. · Via GlobeNewswire · April 9, 2026
Occidental and its co-owners are evaluating results to determine next steps
By Occidental · Via GlobeNewswire · April 9, 2026
New preclinical data for FHD-909 (LY4050784) reinforcing the potential for expansion opportunities in combination with an anti-PD-1 antibody in SMARCA4 (BRG1)-mutant lung cancer
By Foghorn Therapeutics, Inc. · Via GlobeNewswire · April 9, 2026
TORONTO and HOUSTON, April 09, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer and autoimmune diseases, today announced the appointment of Dr. Nageatte Ibrahim, MD, as Chief Medical Officer. Dr. Ibrahim will serve in a fractional capacity, bringing extensive clinical development and oncology expertise to support the advancement of the Company’s pipeline.
By Medicenna Therapeutics Corp. · Via GlobeNewswire · April 9, 2026
RICHMOND, Va., April 09, 2026 (GLOBE NEWSWIRE) -- Indivior Pharmaceuticals, Inc. (Nasdaq: INDV) today announced that it will report its first quarter 2026 financial results on Thursday, April 30, 2026, at 7:00 a.m. U.S. EDT. Following the release of the financial results, Joe Ciaffoni, Chief Executive Officer, and other members of Indivior’s leadership team will host a presentation via live webcast at 8:00 a.m. U.S. EDT.
By Indivior Pharmaceuticals Inc. · Via GlobeNewswire · April 9, 2026
PORTLAND, Tenn., April 09, 2026 (GLOBE NEWSWIRE) -- Shoals Technologies Group, Inc. (the “Company”) (Nasdaq: SHLS) today announced that the Company will release its first quarter 2026 results before market open on Tuesday, May 5, 2026, to be followed by a conference call at 8:00 a.m. (Eastern Time) on the same day.
By Shoals Technologies Group · Via GlobeNewswire · April 9, 2026
Sale to Vireo Growth enhances focus on North American consumer lawn and garden business
By Scotts Miracle-Gro Company (The) · Via GlobeNewswire · April 9, 2026
INGELHEIM, Germany and RIDGEFIELD, Connecticut and NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- Boehringer Ingelheim and Click Therapeutics today announced a strategic agreement to support the commercialization of CT-155, an investigational prescription digital therapeutic that is being studied for the treatment of the experiential negative symptoms of schizophrenia in adults aged 18 years and older.3 Under the agreement, Boehringer will transfer full product responsibility, including all commercial and marketing authorization rights, to Click Therapeutics. To support this transition, Boehringer has made a $50M Series D strategic investment and provided dedicated commercial funding to help bring CT-155 to patients, if cleared by the FDA. CT-155 was co-developed by Boehringer and Click.
By Click Therapeutics · Via GlobeNewswire · April 9, 2026
Each Peanut Buddah Cup brings your sweet tooth a classic combo of peanut butter and chocolate, with an elevated twist of high-dose, hemp-derived THC and CBG.
By RYTHM, Inc. · Via GlobeNewswire · April 9, 2026
Company to present at Talman House (April 13) and ICBC (April 13–15) in Berlin and participate in the Global Cannabis Regulatory Summit in London (April 19–21)
By Rubicon Organics · Via GlobeNewswire · April 9, 2026
FRISCO, Texas and AUSTIN, Texas, April 09, 2026 (GLOBE NEWSWIRE) -- Soleo Health, an innovative leader and national provider of complex specialty pharmacy services, announced today the opening of its new ambulatory infusion center (AIC) in Austin, Texas, expanding access to advanced medications and clinical expertise for patients in the Austin metro area, including Georgetown, San Marcos, and surrounding communities.
By Soleo Health Holdings, Inc. · Via GlobeNewswire · April 9, 2026
Client also negotiating to be primary distributor of PyroGenesis’ titanium powder for Asian market
By PyroGenesis Inc. · Via GlobeNewswire · April 9, 2026
Agreement Focused on Developing DACs With Payloads For Two Oncology Targets, With an Option for a Third Target
By C4 Therapeutics, Inc. · Via GlobeNewswire · April 9, 2026
RONKONKOMA, N.Y., April 09, 2026 (GLOBE NEWSWIRE) -- SUNation Energy, Inc. (Nasdaq: SUNE) (“SUNation” or “the Company”), a leading provider of residential and commercial solar energy systems, battery storage solutions, and comprehensive energy services, today announced that its Board of Directors has authorized the review of a full range of strategic alternatives aimed at increasing shareholder value and best positioning the Company for long-term success.
By SUNation Energy, Inc. · Via GlobeNewswire · April 9, 2026
MINNEAPOLIS and OAKLAND, Calif., April 09, 2026 (GLOBE NEWSWIRE) -- Back to the Roots, America’s leading organic gardening company, today announced a Spring season expansion with Target, marking a milestone ninth year of a partnership that has evolved from a single product to a comprehensive, end-to-end organic gardening destination.
By Back to the Roots · Via GlobeNewswire · April 9, 2026
Strong financial position supports ‘A’ ratings across life and annuity companies and underpins continued global expansion
By Brookfield Wealth Solutions · Via GlobeNewswire · April 9, 2026
NoLimit is building private, uncensored AI infrastructure for businesses that refuse to send their data to Big Tech
By Everything Blockchain, Inc. · Via GlobeNewswire · April 9, 2026
Advancing Evaluation of Potential Development Options
By Paramount Gold Nevada Corp. · Via GlobeNewswire · April 9, 2026
LAS VEGAS, April 09, 2026 (GLOBE NEWSWIRE) -- Premier Development & Investment, Inc. (OTC: PDIV) (“The Company” or “Premier”) advises that it will be filing very material updates in and during the coming days.
By Premier Development & Investment, Inc. · Via GlobeNewswire · April 9, 2026
VANCOUVER, British Columbia, April 09, 2026 (GLOBE NEWSWIRE) -- Equinox Gold Corp. (TSX: EQX, NYSE American: EQX) (“Equinox Gold” or the “Company”) is pleased to announce production results for the three months ended March 31, 2026 (“Q1” or the “Quarter”), along with an update on operations at its two Canadian cornerstone assets: Valentine Gold Mine (“Valentine”) in Newfoundland & Labrador and Greenstone Gold Mine (“Greenstone”) in Ontario. All dollar figures are in United States dollars unless otherwise noted.
By Equinox Gold Corp. · Via GlobeNewswire · April 9, 2026
QUEBEC CITY, April 09, 2026 (GLOBE NEWSWIRE) -- Predictive Discovery Limited (ASX: PDI) (“PDI”) and Robex Resources Inc. (ASX: RXR, TSX-V: RBX) (“Robex”) are pleased to advise the detailed implementation timetable for the merger between the companies (the “Transaction”).
By Robex Resources Inc. · Via GlobeNewswire · April 9, 2026
METTAWA, Ill., April 09, 2026 (GLOBE NEWSWIRE) -- Brunswick Corporation (NYSE: BC) will release its 2026 first quarter financial results on Thursday, April 30, 2026, before the market opens by way of an advisory release, notifying the public that the complete and full-text results will be available on the Company’s website. The results will also be available on the SEC’s website with the Form 8-K filing of the release.
By Brunswick Corporation · Via GlobeNewswire · April 9, 2026
The State of Digital Adoption 2026 reveals a widening trust gap between executives and workers
By WalkMe Inc. · Via GlobeNewswire · April 9, 2026
Stay legal. Stay trained. Stay confident.
By Delta Defense · Via GlobeNewswire · April 9, 2026
Online Sustainability Resource Debuts New Children’s Sustainability Coloring Book, Glossary of Sustainability, and New Educator Bundle to Make Sustainability Education More Accessible
By Finch Insights · Via GlobeNewswire · April 9, 2026
• Adam Schayowitz, Ph.D., MBA appointed as Head of R&D• Scott Platshon appointed as Chief Business Officer
By Zymeworks Inc. · Via GlobeNewswire · April 9, 2026
By MEXC · Via GlobeNewswire · April 9, 2026
GEN Korean BBQ Expands KBBQ Meat & Restaurant Experience with Launch of New Retail Products Inspired by Fan-Favorite Flavors
By GEN Restaurant Group, Inc. · Via GlobeNewswire · April 9, 2026
